Revisiting ASCOT 16 years later

Affiliations

¹ Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham 1034, AL, USA. Electronic address: soparil@uabmc.edu.
² University of South Alabama, Mobile, AL, USA.

Comment

Suzanne Oparil et al. Lancet. 2018.

. 2018 Sep 29;392(10153):1092-1094.

doi: 10.1016/S0140-6736(18)31943-3. Epub 2018 Aug 26.

¹ Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham 1034, AL, USA. Electronic address: soparil@uabmc.edu.
² University of South Alabama, Mobile, AL, USA.

No abstract available

Comment on

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P. Gupta A, et al. Lancet. 2018 Sep 29;392(10153):1127-1137. doi: 10.1016/S0140-6736(18)31776-8. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158072 Clinical Trial.